BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu ZH, Yang CL, Yang GG, Pan WX, Tian LG, Zheng JX, Lv S, Zhang SY, Zheng PY, Zhang SX. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial. Infect Dis Poverty 2021;10:31. [PMID: 33731163 DOI: 10.1186/s40249-021-00813-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadi A, Balan I, Yadav S, Matos WF, Kharawala A, Gaddam M, Sarabia N, Koneru SC, Suddapalli SK, Marzban S. Post-COVID-19 Pulmonary Fibrosis. Cureus 2022;14:e22770. [PMID: 35371880 DOI: 10.7759/cureus.22770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhang SX, Qiu L, Li C, Zhou W, Tian LM, Zhang HY, Ma ZF, Wu XW, Huang X, Jiang YW, Zhang SY, Lu ZH. Efficacy of integrating short-course chemotherapy with Chinese herbs to treat multi-drug resistant pulmonary tuberculosis in China: a study protocol. Infect Dis Poverty 2021;10:131. [PMID: 34742353 DOI: 10.1186/s40249-021-00913-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen M, Ai L, Huang D, Chen J, Feng T, Mei S, Huang Y, Peng B, Zhang S, Zhang R, Zhou X. Soaring Asymptomatic Infected Individuals Bring About Barriers and Difficulties for Interruption of COVID-19 Prevalence in China. Vector Borne Zoonotic Dis 2021. [PMID: 34375121 DOI: 10.1089/vbz.2021.0023] [Reference Citation Analysis]
4 Yu J, Yang M, Han J, Pang X. Fungal and mycotoxin occurrence, affecting factors, and prevention in herbal medicines: a review. Toxin Reviews. [DOI: 10.1080/15569543.2021.1925696] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]